This clinical trial aims to test the effectiveness of ELLASI intervention in response time, deterioration score, and metabolic status of polytrauma patients in the emergency department. The main questions it aims to answer are: 1. Is the response time of polytrauma patients who receive ELLASI in the intervention group faster than the control group? 2. Is the deterioration score of polytrauma patients who receive ELLASI in the intervention group better than the control group? 3. Is the metabolic status of polytrauma patients who receive ELLASI in the intervention group better than the control group? Polytrauma patients in the intervention group will receive ELLASI, a structured intervention consisting of the six following: 1. Evaluation of airway and cervical control, remove the foreign body, fluid, etc., from the airway, 2. Patient positioning and giving oxygen, head-up, 3. Stabilisation, including IV insertion, applying pressure and bandage, place monitor, and haemodynamic monitoring 4. Assessment: re-assessment of pain and other main complaints 5. Make sure informed consents are documented 6. Inform patient and family for further intervention Polytrauma patients in the control group will receive the usual/standard intervention. Response time, early warning score, and arterial blood gas of polytrauma patients from both groups will be obtained and documented before and after the intervention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
48
RSCM
Jakarta Pusat, West Java, Indonesia
RECRUITINGResponse time
Documented from the beginning of ELLASI and standard interventions are delivered to the ending.
Time frame: Immediately before and after the intervention
Deterioration score
Measured with Early Warning Score system used in the hospital where the data was collected. The scores range from 0 to 14. Higher scores mean deterioration
Time frame: Immediately before the intervention start and 3 hours after the intervention end
Acidic Level (pH)
Measure pH of arterial blood gas
Time frame: Immediately before the intervention start and 3 hours after the intervention end
Base Excess (BE)
Measure BE of arterial blood gas
Time frame: Immediately before the intervention start and 3 hours after the intervention end
Bicarbonate level (HCO3)
Measure HCO3 of arterial blood gas
Time frame: Immediately before the intervention start and 3 hours after the intervention end
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.